Baseline and 9 months IVUS analysis of the bifurcation‐dedicated biolimus A9‐eluting Axxess stent system: The DIVERGE IVUS substudy

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-726x|84|7|1062-1070

ISSN： 1522-1946

Source： CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol.84, Iss.7, 2014-12, pp. : 1062-1070

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Outcomes following implantation of the biolimus A9‐eluting BioMatrix coronary stent: Primary analysis of the e‐BioMatrix registry

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 7, 2015-12 ,pp. : 1151-1160

John Wiley & Sons Inc

Access to resources Recommend Favorite

First‐in‐Man Study of Dedicated Bifurcation Sirolimus‐eluting Stent: 12‐month Results of BiOSS LIM® Registry

By  

JOURNAL OF INTERVENTIONAL CARDIOLOGY, Vol. 28, Iss. 1, 2015-02 ,pp. : 51-60

John Wiley & Sons Inc

Access to resources Recommend Favorite

Self‐Expanding Dedicated Bifurcation Stent

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1071-1072

John Wiley & Sons Inc

Access to resources Recommend Favorite

Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the tryton bifurcation stent in conjunction with an everolimus‐eluting stent: IUVANT (Intravascular ultrasound evaluation of tryton stent) study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. 4, 2015-03 ,pp. : 544-553

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioabsorbable polymer‐coated sirolimus‐eluting stent implantation preserves coronary vasomotion: A DESSOLVE II trial sub‐study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. 7, 2015-12 ,pp. : 1141-1150

John Wiley & Sons Inc

Access to resources Recommend Favorite